JAK1
MOLECULAR TARGETTyrosine-protein kinase JAK1
JAK1 (Tyrosine-protein kinase JAK1) is targeted by 59 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting JAK1
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
Showing top 50 of 59 compounds. Use the BiohacksAI search to explore all JAK1 modulators.
About JAK1 as a Drug Target
JAK1 (Tyrosine-protein kinase JAK1) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 59 compounds with documented JAK1 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
JAK1 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.